Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose

Author:

Garg VikasORCID,Gangadharaiah Bharath B,Rastogi Sameer,Upadhyay Ashish,Barwad Adarsh,Dhamija Ekta,Gamangatti Shivanand

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. IARC Publications Website – WHO classification of tumours [Internet]. [cited 2021 Feb 8]. Available from: 〈https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours〉.

2. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma Group;Penel;Eur J Cancer Oxf Engl 1990,2017

3. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG);Kasper;Ann Oncol,2017

4. Evaluation of the long term outcome of patients with extremity desmoids;Chew;Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol,2004

5. Desmoid tumors: a comprehensive review of the evolving biology, unpredictable behavior, and myriad of management options;Devata;Hematol Oncol Clin North Am,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3